Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report

A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented?

(2012) Alexandra Alvarsson et al.   Cardiovascular Diabetology

Effect of Simvastatin and Fenofibrate on Cytokine Release and Systemic Inflammation in Type 2 Diabetes Mellitus With Mixed Dyslipidemia

(2011) Robert Krysiak et al.   AMERICAN JOURNAL OF CARDIOLOGY

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study

(2011) Sandra N Verhagen et al.   Cardiovascular Diabetology

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus

(2011) Mikael K Poulsen et al.   Cardiovascular Diabetology

Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

(2011) Burton E. Sobel et al.   CIRCULATION

Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study

(2011) Ana María Wägner et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects

(2011) J. Joya-Galeana et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation – The Hoorn Study

(2011) Hanneke J.B.H. Beijers et al.   THROMBOSIS RESEARCH

An update on markers of carotid atherosclerosis in patients with Type 2 diabetes

(2010) Nikolaos PE Kadoglou et al.   Biomarkers in Medicine

Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients

(2008) Aysen Akalin et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes

(2007) Ilse Mertens et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome

(2007) Cristina Bianchi et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES